Abstract
Increased rejection risk due to heightened immune reactivity in patients with active systemic lupus erythematous (SLE) previously precluded consideration of solid organ transplantation. However, favorable experience with renal transplantation in this population has advanced the field to a few heart and heart-lung transplantations as well.1,2 We report our experience with left ventricular assist device (LVAD) support with the EXCOR (Berlin Heart GmbH, Berlin, Germany) in an adolescent patient with SLE as a bridge-to-decision and, ultimately, to transplantation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
